Asian press release distribution

Press Releases for Wednesday, August 24, 2022

维信金科2022中期实现稳健业绩 20:57 HKT/SGT

維信金科2022中期實現穩健業績 20:56 HKT/SGT

VCREDIT 1H2022 Achieves a Solid Performance 20:55 HKT/SGT

兆科眼科公布2022中期业绩 20:39 HKT/SGT

兆科眼科公佈2022中期業績 20:38 HKT/SGT

Zhaoke Ophthalmology Announces 2022 Interim Results 20:37 HKT/SGT

Eisai Inc. Collaborates with C2N to Build Awareness and Real-World Evidence for Blood-based Assays 15:18 HKT/SGT

トヨタとKINTO、「KINTO FACTORY」の対象ラインアップへ、GRヤリスを新たに追加 14:00 HKT/SGT

米国子会社エーザイ・インクが米国の実臨床において認知機能障害当事者様に対する血液検査法の活用について、認知度向上とリアルワールド・エビデンス構築に向けてC2N Diagnostics社と協働 13:00 HKT/SGT

重磅深睿医疗6大创新任务荣登工信部、药监局揭榜名单 12:52 HKT/SGT

重磅深睿醫療6大創新任務榮登工信部、藥監局揭榜名單 12:51 HKT/SGT

GR Yaris Joins KINTO FACTORY Lineup 12:38 HKT/SGT

Subang Parade Holds Merdeka Fiesta to Celebrate National Day 11:00 HKT/SGT

顺势而为，坚定转型，光大环境公布2022年上半年业绩 10:47 HKT/SGT

順勢而為，堅定轉型，光大環境公佈2022年上半年業績 10:46 HKT/SGT

中国抗体宣布SN1011针对视神经脊髓炎谱系疾病的新药研究申请获国家药监局批准 08:07 HKT/SGT

中國抗體宣佈SN1011針對視神經脊髓炎譜系疾病的新藥研究申請獲國家藥監局批准 08:06 HKT/SGT

Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA 08:05 HKT/SGT

寶尊電商2022Q2財報：戰略業務穩步推進持續創新賦能品牌數字化轉型 08:01 HKT/SGT

宝尊电商2022Q2财报：战略业务稳步推进持续创新赋能品牌数字化转型 08:00 HKT/SGT

Avantor and Avantor Foundation Make a Difference by Providing Critical Health Services for Vulnerable Communities in Singapore 07:55 HKT/SGT

How Stars.Art is Changing the Global NFT Arena: New Perspectives for Creators and Collectors 07:30 HKT/SGT

ACN Search:

Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Cookies Policy \| Privacy Policy \| Disclaimer \| Terms of Use \| RSS

US: +1 214 890 4418 \| China: +86 181 2376 3721 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575